To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

PHASE3CompletedINTERVENTIONAL
Enrollment

1,164

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Osteoarthritis
Interventions
DRUG

Diclofenac Sodium gel, 1%

DRUG

Voltaren® Gel

DRUG

Placebo

Trial Locations (44)

Unknown

Glenmark Investigational Site 5, Mesa

Glenmark Investigational Site 1, Anaheim

Glenmark Investigational Site 21, Anaheim

Glenmark Investigational Site 31, Anaheim

Glenmark Investigational Site 26, Canoga Park

Glenmark Investigational Site 42, Carlsbad

Glenmark Investigational Site 30, Carmichael

Glenmark Investigational Site 33, Cerritos

Glenmark Investigational Site 25, El Cajon

Glenmark Investigational Site 24, La Mesa

Glenmark Investigational Site 2, Pasadena

Glenmark Investigational Site 13, Rancho Cucamonga

Glenmark Investigational Site 27, Sacramento

Glenmark Investigational Site 10, Fort Lauderdale

Glenmark Investigational Site 41, Hialeah

Glenmark Investigational Site 15, Miami

Glenmark Investigational Site 19, Miami

Glenmark Investigational Site 28, Miami

Glenmark Investigational Site 32, Miami

Glenmark Investigational Site 40, Miami

Glenmark Investigational Site 3, Miami Lakes

Glenmark Investigational Site 37, Ormond Beach

Glenmark Investigational Site 11, West Palm Beach

Glenmark Investigational Site 18, West Palm Beach

Glenmark Investigational Site 8, Evanston

Glenmark Investigational Site 43, Newburgh

Glenmark Investigational Site 38, Wichita

Glenmark Investigational Site 17, New Orleans

Glenmark Investigational Site 22, Saginaw

Glenmark Investigational Site 14, St Louis

Glenmark Investigational Site 9, Englewood

Glenmark Investigational Site7, Altoona

Glenmark Investigational Site 36, Knoxville

Glenmark Investigational Site 39, Nashville

Glenmark Investigational Site 23, Beaumont

Glenmark Investigational Site 20, Bryan

Glenmark Investigational Site 34, Dallas

Glenmark Investigational Site 35, Houston

Glenmark Investigational Site 44, Houston

Glenmark Investigational Site 4, Lampasas

Glenmark Investigational Site 29, San Antonio

Glenmark Investigational Site 6, San Antonio

Glenmark Investigational Site 16, Charlottesville

Glenmark Investigational Site12, Midlothian

All Listed Sponsors
lead

Glenmark Pharmaceuticals Ltd. India

INDUSTRY

NCT02596451 - To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion). | Biotech Hunter | Biotech Hunter